Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids.
Dienoic eicosanoids derived from phospholipid arachidonic acid (AA) in lung and liver macrophages promote leukosequestration, thrombosis, and tissue injury. Current enteral diets (diet A) are enriched with linoleic acid (LA), a precursor of AA. Novel diets low in LA and containing eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA) foster formation of less inflammatory eicosanoids. The study objective was to assess the rapidity and extent of LA and AA displacement in vivo from alveolar macrophage (AM phi), lung, and liver Kupffer and endothelial (KE) cell phospholipids in rats fed enterally with diets enriched with 5.3% (by wt) EPA and either 1.2% or 4.6% GLA (diets B and C, respectively). After surgical placement of catheters, the rats were fed enterally and co-infused intravenously with either endotoxin or vehicle continuously for 3 or 6 d. Rats given either diet B or C had significantly lower (P < 0.01) relative percentages of AA and LA within the AM phi, lung, and KE cell phospholipids, and concomitantly higher percentages of EPA compared with rats infused with diet A after 3 d of enteral feeding irrespective of endotoxin co-infusion. Incorporation of dihomo-gamma-linolenic acid (DHGLA), the metabolite of GLA, into lung and KE phospholipids was significant in rats given diet C. Most of the changes in fatty acid composition occurred by day 3. The polyunsaturated fatty acid composition of AM phi, lung, and KE cell phospholipids can be rapidly modified by continuous short-term enteral feeding with EPA- and GLA-enriched diets irrespective of concurrent endotoxemia.
Palombo
J D
JD
Department of Surgery and Medicine, New England Deaconess Hospital, Boston, MA 02215, USA.
DeMichele
S J
SJ
Lydon
E E
EE
Gregory
T J
TJ
Banks
P L
PL
Forse
R A
RA
Bistrian
B R
BR
D000818:Animals; D002855:Chromatography, Thin Layer; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D004731:Endotoxins / Q000008:administration & dosage; D004750:Enteral Nutrition; D015622:Epithelioid Cells / Q000378:metabolism; D004926:Escherichia coli; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D007262:Infusions, Intravenous; D007728:Kupffer Cells / Q000378:metabolism; D008099:Liver / Q000166:cytology*; D008168:Lung / Q000166:cytology*; D008264:Macrophages / Q000378:metabolism*; D016676:Macrophages, Alveolar / Q000378:metabolism; D008297:Male; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D014115:Toxemia / Q000378:metabolism*; D017965:gamma-Linolenic Acid / Q000008:administration & dosage*
D004731:Endotoxins; D005231:Fatty Acids, Unsaturated; D017965:gamma-Linolenic Acid; D015118:Eicosapentaenoic Acid